CAAS Capital Management’s CVS Health CVS Stock Holding History

CAAS Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$2.74M	Buy	+40,400	New	+$2.42M	0.29%	78
2024 Q1	–	Sell	-18,600	Closed	-$1.47M	–	539
2023 Q4	$1.47M	Buy	18,600 +200	+1%	+$14.2K	0.16%	145
2023 Q3	$1.28M	Sell	18,400 -63,900	-78%	-$4.53M	0.08%	228
2023 Q2	$5.69M	Buy	82,300 +80,300	+4,015%	+$5.71M	0.38%	76
2023 Q1	$149K	Buy	+2,000	New	+$168K	0.01%	590
2022 Q3	–	Sell	-10,900	Closed	-$1.01M	–	862
2022 Q2	$1.01M	Sell	10,900 -44,500	-80%	-$4.34M	0.05%	370
2022 Q1	$5.61M	Buy	55,400 +5,400	+11%	+$567K	0.23%	122
2021 Q4	$5.16M	Hold	50,000	–	–	0.13%	182
2021 Q3	$4.24M	Hold	50,000	–	–	0.09%	223
2021 Q2	$4.17M	Hold	50,000	–	–	0.07%	272
2021 Q1	$3.76M	Buy	+50,000	New	+$3.64M	0.04%	422

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CAAS Capital Management's CVS Position: Q3 2023 in Review

CAAS Capital Management sold out of CVS Health (CVS) in Q3 2023, closing a stake of 20,570 shares — an estimated $1.46M sold.

CAAS Capital Management first reported a position in CVS in Q2 2021 and held it in 6 quarters. The position peaked at $1.42M in Q2 2023. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

CAAS Capital Management reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
CAAS Capital Management sold 20,570 CVS Health shares in Q3 2023, an estimated $1.46M.
CAAS Capital Management first reported a position in CVS Health in Q2 2021 and held it in 6 quarters.
CAAS Capital Management's CVS Health position peaked at $1.42M in Q2 2023.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on CAAS Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.